Synonyms:bumetanide, 28395-03-1, 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid, Bumex, Burinex, Fordiuran, Lunetoron, Fontego, Segurex, Ro 10-6338, Bumetanida, Bumetanidum, Bumetanidum [INN-Latin], PF 1593, Bumetanida [INN-Spanish], 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid, Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-, C17H20N2O5S, Bumetanide (Ro 10-6338), 0Y2S3XUQ5H, Ro-10-6338, MLS000028457, CHEBI:3213, Aquazone, Butinat, Cambiex, Diurama, DTXSID5022699, Yurinex, BENZOIC ACID, 3-(BUTYLAMINO)-4-PHENOXY-5-SULFAMOYL-, Burine, 3-butylamino-4-phenoxy-5-sulfamoyl-benzoic acid, 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid, Lixil-Leo, Ro-106338, NCGC00015149-02, SMR000058418, Lixil, CAS-28395-03-1, Ro 10-6338;PF 1593, 3-butylamino-4-phenoxy-5-sulfamoylbenzoic acid, S95008., S-95008., DTXCID702699, Bufenox, Bumex (TN), SR-01000003062, EINECS 249-004-6, UNII-0Y2S3XUQ5H, BRN 2185351, Bumetanide in bulk, 82U, Prestwick_679, MFCD00078949, Bumetanide [USAN:USP:INN:BAN:JAN], Spectrum_001317, Bumetanide, >=98%, BUMETANIDE [MI], BUMETANIDE [INN], BUMETANIDE [JAN], Opera_ID_1734, Prestwick0_000276, Prestwick1_000276, Prestwick2_000276, Prestwick3_000276, Spectrum2_001050, Spectrum3_001481, Spectrum4_000030, Spectrum5_001212, BUMETANIDE [USAN], Lopac-B-3023, BUMETANIDE [VANDF], B 3023, BUMETANIDE [MART.], cid_2471, BUMETANIDE [USP-RS], BUMETANIDE [WHO-DD], CHEMBL1072, Lopac0_000162, SCHEMBL27525, BSPBio_000152, BSPBio_001508, BSPBio_003061, KBioGR_000228, KBioGR_000439, KBioSS_000228, KBioSS_001797, 3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoic acid, MLS001148265, DivK1c_000034, SPECTRUM1502004, SPBio_000980, SPBio_002371, BPBio1_000168, Bumetanide (JP17/USP/INN), GTPL4837, BUMETANIDE [EP IMPURITY], BUMETANIDE [ORANGE BOOK], BDBM25903, HMS500B16, KBio1_000034, KBio2_000228, KBio2_001797, KBio2_002796, KBio2_004365, KBio2_005364, KBio2_006933, KBio3_000455, KBio3_000456, KBio3_002561, BUMETANIDE [EP MONOGRAPH], NINDS_000034, 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid, Bio1_000421, Bio1_000910, Bio1_001399, Bio2_000228, Bio2_000708, BUMETANIDE [USP MONOGRAPH], HMS1361L10, HMS1568H14, HMS1791L10, HMS1921B20, HMS1989L10, HMS2089P13, HMS2092N03, HMS2095H14, HMS2230P15, HMS3259O08, HMS3260B05, HMS3374E02, HMS3402L10, HMS3654B13, HMS3712H14, HMS3873C13, Pharmakon1600-01502004, BCP28485, Tox21_110088, Tox21_500162, CCG-40125, NSC758145, s1287, AKOS015896600, Tox21_110088_1, AC-8115, CS-1821, DB00887, KS-5211, LP00162, NC00550, NSC 758145, NSC-758145, SDCCGSBI-0050150.P004, IDI1_000034, IDI1_033978, SMP1_000049, NCGC00015149-01, NCGC00015149-03, NCGC00015149-04, NCGC00015149-05, NCGC00015149-06, NCGC00015149-07, NCGC00015149-08, NCGC00015149-09, NCGC00015149-10, NCGC00015149-11, NCGC00015149-12, NCGC00015149-13, NCGC00015149-15, NCGC00015149-16, NCGC00015149-26, NCGC00022072-03, NCGC00022072-04, NCGC00022072-05, NCGC00022072-06, NCGC00022072-07, NCGC00022072-08, NCGC00260847-01, HY-17468, SBI-0050150.P003, AB00052253, EU-0100162, SW196834-3, D00247, EN300-122330, 3-butylamino-4-phenoxy-5-sulphamyl-benzoic acid, AB00052253-15, AB00052253-16, AB00052253_17, AB00052253_18, 3-n-butylamino-4-phenoxy-5-sulfamyl-benzoic acid, 3-n-butylamino-4-phenoxy-5-sulphamyl-benzoic acid, A819434, Q275926, J-017055, SR-01000003062-2, SR-01000003062-4, SR-01000003062-7, BRD-K38197229-001-06-7, BRD-K38197229-001-17-4, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-benzoic acid, Z1541758727, 3-(BUTYLAMINO)-4-PHENOXY-5-SULFAMOYLBENZOIC ACID., Bumetanide, British Pharmacopoeia (BP) Reference Standard, Bumetanide, European Pharmacopoeia (EP) Reference Standard, Bumetanide, United States Pharmacopeia (USP) Reference Standard, Ro 10-6338; PF 1593 pound>>Ro-10-6338; PF1593 pound>>Ro10-6338; PF-1593
Pubchem:PUBCHEM:2471
Id:34a7d574-7dbd-52de-83b4-3913846343c8
Description:nan
